3,4-dihydroxyphenylacetic acid has been researched along with sapropterin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anastasiadis, PZ; Kuhn, DM; Levine, RA; States, JC | 1 |
| Hossain, MA; Weiner, N | 1 |
| Arnold, LA; Blanchet, PJ; Chase, TN; Hyland, K; Konitsiotis, S; Pettigrew, KD | 1 |
| Cianchetti, C; di Porzio, U; Lilliu, V; Mancosu, C; Sorrentino, G; Zuddas, A | 1 |
| Cho, Y; Choi, HJ; Hwang, O; Lee, SY | 1 |
5 other study(ies) available for 3,4-dihydroxyphenylacetic acid and sapropterin
| Article | Year |
|---|---|
Co-induction of tetrahydrobiopterin (BH4) levels and tyrosine hydroxylase activity in cultured PC12 cells.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenal Gland Neoplasms; Analysis of Variance; Animals; Biopterins; Dihydroxyphenylalanine; Dopamine; Enzyme Induction; Epinephrine; Homovanillic Acid; Kinetics; Norepinephrine; PC12 Cells; Pheochromocytoma; Rats; Serotonin; Tyrosine 3-Monooxygenase | 1993 |
Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biopterins; Brain Diseases; Carbidopa; Corpus Striatum; Cyclic AMP; Disease Models, Animal; Dopamine; Dopamine D2 Receptor Antagonists; Homovanillic Acid; Levodopa; Male; Oxidopamine; Parkinson Disease; Rats; Rats, Inbred F344; Receptors, Dopamine D1; Receptors, Dopamine D2; Sensitivity and Specificity; Substantia Nigra; Time Factors | 1993 |
Chronic exposure to MPTP as a primate model of progressive parkinsonism: a pilot study with a free radical scavenger.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Biomarkers; Biopterins; Disease Models, Animal; Female; Free Radical Scavengers; Homovanillic Acid; Indans; Macaca fascicularis; Male; Methoxyhydroxyphenylglycol; Motor Activity; Parkinson Disease, Secondary; Pilot Projects; Piperazines | 1998 |
6R-Tetrahydrobiopterin induces dopamine synthesis in a human neuroblastoma cell line, LA-N-1. A cellular model of DOPA-responsive dystonia.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Biopterins; Dopamine; Dopamine Antagonists; Dystonic Disorders; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Models, Biological; Monoamine Oxidase Inhibitors; Neuroblastoma; Neurons; Serotonin; Serotonin Antagonists; Substantia Nigra; Tryptophan Hydroxylase; Tumor Cells, Cultured; Tyrosine 3-Monooxygenase | 2002 |
Inhibition of vesicular monoamine transporter enhances vulnerability of dopaminergic cells: relevance to Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcysteine; Animals; Benzoquinones; Biopterins; Cell Death; Cell Line; Cytosol; Dimethyl Fumarate; Dopamine; Drug Resistance; Enzyme Inhibitors; Fumarates; Ketanserin; Lipid Peroxidation; Membrane Glycoproteins; Membrane Transport Modulators; Membrane Transport Proteins; Mice; Monoamine Oxidase Inhibitors; Neurons; Oxidative Stress; Parkinson Disease; Substantia Nigra; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2005 |